Support from the Dr. Seymour & Rose T. Brown Professorship helped Dr. Rob Gereau turn an early research idea into a promising path toward safer, more effective treatments for chronic pain.
WashU Medicine researchers have uncovered new insights into the pharmacology of ketamine that help explain both its rapid benefits and its risks.
Finding from mouse study could lead to targeted treatments for chronic nerve pain.
Mouse study finds changes to DNA packaging form molecular memory of trauma, make brain vulnerable to future stress.
According to the U.S. Pain Foundation, chronic pain affects millions of people and can impact nearly every part of daily life – sleep, exercise, work, relationships and emotional well-being. Felicitas Huber, PhD, a WashU Medicine pain psychologist, says that treatment often requires more than medication alone.
Dr. Ream Al-Hasani has received a $3.5 million grant from the National Institute on Drug Abuse within the National Institutes of Health (NIH) to study how exposure to opioids before birth affects long-term brain development and behavior.
Researchers from the WashU Medicine Department of Anesthesiology had an impactful presence at the American Headache Society (AHS) Annual Meeting, held June 4–7, 2026, in Orlando. With major awards, national recognition, and multiple scientific presentations, the department once again demonstrated its leadership in headache and migraine research.
After a below-the-knee amputation, Jodi Evans experienced severe phantom limb pain that disrupted her sleep and daily life. A spinal cord stimulator helped reduce the pain, allowing her to rest and regain independence.
At WashU Medicine Pain Center, specialists across disciplines collaborate to diagnose and treat how patients experience chronic pain.
Dr. Sarah Buday, WashU Medicine associate professor of anesthesiology, and Corey Woldenberg, WashU Medicine assistant professor of physical therapy and othopaedic surgery, spoke with Ladue News about interdisciplinary pain management for neuroplastic pain.